These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 7170355)

  • 21. Directions in radionuclide hepatobiliary imaging.
    Rosenthall L
    J Can Assoc Radiol; 1980 Dec; 31(4):220-4. PubMed ID: 6778881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatobiliary functional scintigraphy of the liver].
    Wetzel E; zum Winkel K
    Rontgenpraxis; 1979 Aug; 32(8):185-93. PubMed ID: 524206
    [No Abstract]   [Full Text] [Related]  

  • 23. Radionuclide studies of the liver and hepatobiliary system.
    Kim EE; Podoloff DA
    Curr Opin Radiol; 1990 Dec; 2(6):844-50. PubMed ID: 2282260
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of hepatic function by hepatobiliary scintigraphy using factor analysis].
    Shimomura O; Takahashi M; Tsuji A; Takagi Y; Tomiguchi S; Koga Y; Kojima A; Matsumoto M; Hara M; Hirota Y
    Kaku Igaku; 1989 Feb; 26(2):145-53. PubMed ID: 2733200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatobiliary function test with 99mTc-E-HIDA (author's transl)].
    Nakano S; Hasegawa Y; Shiomura K; Ibuka K; Hashizume T
    Radioisotopes; 1981 May; 30(5):281-4. PubMed ID: 7313147
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatobiliary Scintigram (author's transl)].
    Kuramoto M; Machida K; Nishikawa J; Tasaka A
    Rinsho Hoshasen; 1982 Jan; 27(1):69-71. PubMed ID: 6896221
    [No Abstract]   [Full Text] [Related]  

  • 27. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
    Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
    J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatobiliary scintigraphy using 99mTc-(Sn)-pyridoxylideneisoleucine for the diagnosis of the diffuse liver disease (author's transl)].
    Ito K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Feb; 39(2):132-43. PubMed ID: 450649
    [No Abstract]   [Full Text] [Related]  

  • 29. [The preparation and application of 99mTc-(Sn)-pyridoxylidene tryptophan--a hepatobiliary imaging agent].
    Tan TZ; Li W
    Hua Xi Yi Ke Da Xue Xue Bao; 1987 Jun; 18(2):183-6. PubMed ID: 3623547
    [No Abstract]   [Full Text] [Related]  

  • 30. TC-99m(Sn)-N-pyridoxylaminates: a new series of hepatobiliary imaging agents.
    Kato-Azuma M
    J Nucl Med; 1982 Jun; 23(6):517-24. PubMed ID: 7077403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dynamic study of the biliary tract using hepatobiliary scintigraphy].
    Aburano T
    Nihon Rinsho; 1979 Jun; Suppl():2429-30. PubMed ID: 491176
    [No Abstract]   [Full Text] [Related]  

  • 32. [The evaluation of hepatobiliary scan using 99mTc-HIDA (author's transl)].
    Sasaki Y; Tsujino D; Kato T; Hoshi K; Someya K; Fujii M; Sakaki T; Itagaki K; Nakajima T; Kado B; Kitani K
    Kaku Igaku; 1979 Jun; 16(4):595-603. PubMed ID: 541892
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of 99mTc-N-pyridoxyl-5-methyltryptophan and 99mTc-N-(3-bromo-2,4,6-trimethylacetanilide)-iminodiace tate as hepatobiliary radiopharmaceuticals in rats.
    Fritzberg AR; Bloedow DC; Eshima D; Johnson DL
    J Pharm Sci; 1984 Dec; 73(12):1861-3. PubMed ID: 6527280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectral analysis applied to hepatobiliary dynamic scintigraphy with 99Tcm-N-pyridoxyl-5-methyltryptophan.
    Murase K; Tsuda T; Mochizuki T; Tanada S; Ikezoe J
    Nucl Med Commun; 1997 Nov; 18(11):1049-56. PubMed ID: 9423205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vivo 75Se methionine metabolism in diseases of the hepatobiliary system].
    Palinkashi DG
    Med Radiol (Mosk); 1984 May; 29(5):44-9. PubMed ID: 6727599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quest for the perfect hepatobiliary radiopharmaceutical.
    Fritzberg AR; Klingensmith WC
    J Nucl Med; 1982 Jun; 23(6):543-6. PubMed ID: 6896213
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical evaluation of 99mTc-EIDA scan for hepatobiliary disease (author's transl)].
    Itoh K; Saito C; Kamada T; Miyamoto M; Furudate M
    Kaku Igaku; 1981 Dec; 18(10):1443-50. PubMed ID: 7341806
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on the evaluation of the clinical usefulness of 99mTc-(Sn)-pyridoxylidene isoleucine as a cholescintigraphic agent (author's transl)].
    Odori T; Morita R; Saji H; Fujita T; Torizuka K; Horiuchi K; Yokoyama A; Matsuyama H; Muranaka H
    Kaku Igaku; 1979 Aug; 16(5):795-804. PubMed ID: 537242
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro properties and clinical use of 99mTc-3-bromo-2,4,6-trimethyl-IDA in sequential hepatobiliary scintigraphy.
    Camuzzini GF; D'Angeli B; Tortore P; Biggi A; Farinelli MC; Cagnassi S; Papaleo A; Assone F; Lunghi F; Plassio G
    J Nucl Med Allied Sci; 1984; 28(3):167-79. PubMed ID: 6530622
    [No Abstract]   [Full Text] [Related]  

  • 40. [Traumatic bile leakage demonstrated by hepatobiliary scintigraphy--a case report].
    Matsuo Y; Shiozaki H; Baba H; Kishikawa T; Hidaka K; Fujiwara H; Harada S; Hisatsugu T
    Kaku Igaku; 1985 Oct; 22(10):1551-5. PubMed ID: 4094176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.